![]()
|
|
||||||||
J. Biol. Chem., Vol. 282, Issue 21, 15416-15429, May 25, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Periodontology and Oral Biology, Division of Oral Biology, Boston University Goldman School of Dental Medicine, Boston, Massachusetts 02118
Prostaglandin E2 blocks transforming growth factor TGF
1-induced CCN2/CTGF expression in lung and kidney fibroblasts. PGE2 levels are high in gingival tissues yet CCN2/CTGF expression is elevated in fibrotic gingival overgrowth. Gingival fibroblast expression of CCN2/CTGF in the presence of PGE2 led us to compare the regulation of CCN2/CTGF expression in fibroblasts cultured from different tissues. Data demonstrate that the TGF
1-induced expression of CCN2/CTGF in human lung and renal mesangial cells is inhibited by 10 nM PGE2, whereas human gingival fibroblasts are resistant. Ten nM PGE2 increases cAMP accumulation in lung but not gingival fibroblasts, which require 1 µM PGE2 to elevate cAMP. Micromolar PGE2 only slightly reduces the TGF
1-stimulated CCN2/CTGF levels in gingival cells. EP2 prostaglandin receptor activation with butaprost blocks the TGF
1-stimulated expression of CCN2/CTGF expression in lung, but not gingival, fibroblasts. In lung fibroblasts, inhibition of the TGF
1-stimulated CCN2/CTGF by PGE2, butaprost, or forskolin is due to p38, ERK, and JNK MAP kinase inhibition that is cAMP-dependent. Inhibition of any two MAPKs completely blocks CCN2/CTGF expression stimulated by TGF
1. These data mimic the inhibitory effects of 10 nM PGE2 and forskolin that were dependent on PKA activity. In gingival fibroblasts, the sole MAPK mediating the TGF
1-stimulated CCN2/CTGF expression is JNK. Whereas forskolin reduces TGF
1-stimulated expression of CCN2/CTGF by 35% and JNK activation in gingival fibroblasts, micromolar PGE2-stimulated JNK in gingival fibroblasts and opposes the inhibitory effects of cAMP on CCN2/CTGF expression. Stimulation of the EP3 receptor with sulprostone results in a robust increase in JNK activation in these cells. Taken together, data identify two mechanisms by which TGF
1-stimulated CCN2/CTGF levels in human gingival fibroblasts resist down-regulation by PGE2: (i) cAMP cross-talk with MAPK pathways is limited in gingival fibroblasts; (ii) PGE2 activation of the EP3 prostanoid receptor stimulates the activation of JNK.
Received for publication, November 8, 2006 , and in revised form, April 4, 2007.
* This work was supported by National Institutes of Health NIDCR Grants R01 DE11004, K08 DE016609, and M01 RR00533. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: 700 Albany St., Boston, MA 02118. Tel.: 617-638-4076; Fax: 617-638-5265; E-mail: trackman{at}bu.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. A. Black Jr. and P. C. Trackman Transforming Growth Factor-{beta}1 (TGF{beta}1) Stimulates Connective Tissue Growth Factor (CCN2/CTGF) Expression in Human Gingival Fibroblasts through a RhoA-independent, Rac1/Cdc42-dependent Mechanism: STATINS WITH FORSKOLIN BLOCK TGF{beta}1-INDUCED CCN2/CTGF EXPRESSION J. Biol. Chem., April 18, 2008; 283(16): 10835 - 10847. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |